A VHIR team travels to Angola to test, under real-world conditions, an innovative device designed for mass diagnosis in resource-limited settings.

This VHIR initiative promotes well-being, empathy and community participation in Barcelona neighbourhoods through an intergenerational model

The donation raised through ALS, the Musical will support the development of new biomarkers and more personalised research into the disease

The results show that diet induces changes in the gut microbiota that differ between Crohn’s disease and ulcerative colitis, and that influence levels of intestinal inflammation.

The paper describes the case of a patient in whom, years after a bone marrow transplant, two immune cell lines corrected the original genetic defect.

The funds raised will contribute to ensuring the continuity of the pediatric brain tumor research line developed by the Vall d’Hebron research teams.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

The study analyzes a new therapeutic strategy in high-risk patients that could influence future international clinical guidelines

Amb 387 procediments practicats, l’Hospital Vall d’Hebron es consolida al capdavant dels centres capacitats per realitzar trasplantaments en adults i pediàtrics.

The report, published in Nature, reveals that polyamines bind to specific domains in proteins and operate as a metabolic shield against modifications in their structure.

You can now pre-register for the Master’s Degree in Translational Biomedical Research, the Master’s in Health Innovation and Entrepreneurship, and the Master’s in Clinical Trials Management and Coordination.

During the annual meeting, representatives from the different centers participating in the project shared the progress made across the various areas of work.

The project has developed a low-cost system to diagnose malaria and schistosomiasis using artificial intelligence and a robotic microscope.

The collaboration between the Vall d’Hebron Research Institute (VHIR) and the Association for Information and Research on Familial Hypomagnesemia (Hipofam) celebrates ten years.

The aim of the project is to establish kidney organoids derived from patients with familial hypomagnesaemia with hypercalciuria and nephrocalcinosis, which will be essential tools for studying the disease and testing new treatments.

The program aims to foster an innovation-driven culture within the VHIR, improve the management of projects with transfer potential, and promote leading innovation profiles within research groups.

2025 has been an active year with the participation of RADeep members at the Data Access Committee at Vall d’Hebron and the presentation of abstracts at the 67th ASH Annual Meeting and Exposition.

L’aportació permet avançar en estudis de referència internacional i continuar millorant l’atenció dels infants trasplantats de fetge.

Since 2019, Pulseras Candela has been collaborating with the Childhood Cancer and Hematological Diseases group at VHIR on the project “New Therapeutic Approaches for the Treatment of Pediatric Ependymoma.”

The jury has awarded a scientific infrastructure that redefines urban integration, sustainability and collaboration in the Vall d'Hebron.

The session has helped bring the public an up-to-date perspective on diagnosis, treatments, and the research lines that are transforming the future of patients.

The study, conducted with more than 1,400 people with addictive disorders, delves into the biological mechanisms that connect mental health, life trajectory and educational opportunities.

The study will be conducted in the Intensive Care Medicine Service of the Vall d’Hebron University Hospital and will validate the prognostic value of the NLRP3 biomarker.

The donation will boost several lines of research to advance liquid biopsy in pediatric sarcomas and brain tumors.